Mexico Cell and Gene Therapy Market (2025-2031) | Growth, Segmentation, Forecast, Share, Analysis, Size & Revenue, Industry, Competitive Landscape, Outlook, Companies, Value, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Mexico Country Macro Economic Indicators

3.2 Mexico Cell and Gene Therapy Market Revenues & Volume, 2021 & 2031F

3.3 Mexico Cell and Gene Therapy Market - Industry Life Cycle

3.4 Mexico Cell and Gene Therapy Market - Porter's Five Forces

3.5 Mexico Cell and Gene Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

3.6 Mexico Cell and Gene Therapy Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.7 Mexico Cell and Gene Therapy Market Revenues & Volume Share, By Delivery Mode, 2021 & 2031F

3.8 Mexico Cell and Gene Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases in Mexico, driving the demand for advanced treatment options like cell and gene therapy.

4.2.2 Growing investments by the government and private sector in healthcare infrastructure and research facilities for cell and gene therapy.

4.2.3 Rising awareness and acceptance of personalized medicine and innovative therapies among patients and healthcare professionals in Mexico.

4.3 Market Restraints

4.3.1 High costs associated with cell and gene therapy treatments, limiting access to a broader population in Mexico.

4.3.2 Regulatory challenges and uncertainties in the approval process for cell and gene therapy products in Mexico.

4.3.3 Limited availability of skilled professionals and infrastructure for manufacturing and administering cell and gene therapies in Mexico.

6.1 Mexico Cell and Gene Therapy Market, By Therapy Type

6.1.1 Overview and Analysis

6.1.2 Mexico Cell and Gene Therapy Market Revenues & Volume, By Therapy Type, 2021- 2031F

6.1.3 Mexico Cell and Gene Therapy Market Revenues & Volume, By Cell Therapy, 2021- 2031F

6.1.4 Mexico Cell and Gene Therapy Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.2 Mexico Cell and Gene Therapy Market, By Indication

6.2.1 Overview and Analysis

6.2.2 Mexico Cell and Gene Therapy Market Revenues & Volume, By Cardiovascular Disease, 2021- 2031F

6.2.3 Mexico Cell and Gene Therapy Market Revenues & Volume, By Oncology Disorder, 2021- 2031F

6.2.4 Mexico Cell and Gene Therapy Market Revenues & Volume, By Genetic Disorder, 2021- 2031F

6.2.5 Mexico Cell and Gene Therapy Market Revenues & Volume, By Infectious Disease, 2021- 2031F

6.2.6 Mexico Cell and Gene Therapy Market Revenues & Volume, By Neurological Disorder, 2021- 2031F

6.2.7 Mexico Cell and Gene Therapy Market Revenues & Volume, By Others, 2021- 2031F

6.3 Mexico Cell and Gene Therapy Market, By Delivery Mode

6.3.1 Overview and Analysis

6.3.2 Mexico Cell and Gene Therapy Market Revenues & Volume, By In-Vivo, 2021- 2031F

6.3.3 Mexico Cell and Gene Therapy Market Revenues & Volume, By Ex-Vivo, 2021- 2031F

6.4 Mexico Cell and Gene Therapy Market, By End User

6.4.1 Overview and Analysis

6.4.2 Mexico Cell and Gene Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Mexico Cell and Gene Therapy Market Revenues & Volume, By Cancer Care Centers, 2021- 2031F

6.4.4 Mexico Cell and Gene Therapy Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F

6.4.5 Mexico Cell and Gene Therapy Market Revenues & Volume, By Others, 2021- 2031F

7.1 Mexico Cell and Gene Therapy Market Export to Major Countries

7.2 Mexico Cell and Gene Therapy Market Imports from Major Countries

8.1 Patient enrollment in cell and gene therapy clinical trials in Mexico.

8.2 Number of partnerships and collaborations between local and international biotech companies in the cell and gene therapy sector in Mexico.

8.3 Investments in research and development for cell and gene therapy technologies by Mexican pharmaceutical companies.

8.4 Number of approved cell and gene therapy products for commercialization in Mexico.

9.1 Mexico Cell and Gene Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

9.2 Mexico Cell and Gene Therapy Market Opportunity Assessment, By Indication, 2021 & 2031F

9.3 Mexico Cell and Gene Therapy Market Opportunity Assessment, By Delivery Mode, 2021 & 2031F

9.4 Mexico Cell and Gene Therapy Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 Mexico Cell and Gene Therapy Market Revenue Share, By Companies, 2024

10.2 Mexico Cell and Gene Therapy Market Competitive Benchmarking, By Operating and Technical Parameters